182 Results for "

ADC payload

" in MedChemExpress (MCE) Product Catalog:
Products (182)

182 Results for "ADC payload" in MCE Product Catalog:

Cat. No.: HY-171269
Research Areas:  

Cancer

Anetumab-MMAE is an antibody-drug conjugate (ADC) (Anetumab antibody (HY-P99352), Linker: VC linker, Payload: MMAE (HY-15162)). Anetumab is an anti-mesothelin (MSLN) antibody.
loading...
    loading...
Cat. No.: HY-169323
CAS No.: 2921735-87-5
Synonyms: Mal-Exo-EEVC-MMAE
Research Areas:  

Cancer

APL-1091 (Mal-Exo-EEVC-MMAE) is an ADC payload-linker conjugate (Drug-Linker Conjugates for ADC). APL-1091 is formed by the conjugation of the Mal-Exo-EEVC (HY-169353) linker and MMAE (HY-15162), a microtubule inhibitor. APL-1091 resists aggregation at high drug-to-antibody ratio (DAR), exhibits excellent plasma stability, and reduces premature payload release. When conjugated with Trastuzumab (HY-P9907), APL-1091 displays anti-tumor activity in gastric cancer xenograft models. APL-1091 can be used for ADC synthesis and gastric cancer-related research .
loading...
    loading...
Cat. No.: HY-171270
Research Areas:  

Cancer

Clivatuzumab-MMAE is an antibody-drug conjugate (ADC) (Clivatuzumab antibody (HY-P99968), Linker: VC linker, Payload: MMAE (HY-15162)). Anetumab is a humanized anti-mucin monoclonal antibody.
loading...
    loading...
Cat. No.: HY-156756S
Purity:  98.03%
7-Hydroxymethyl-10,11-MDCPT-d5 is deuterium labeled 7-Hydroxymethyl-10,11-MDCPT, which is a is a payload that can be used for ADC synthesis .
loading...
    loading...
Cat. No.: HY-102001
CAS No.: 945490-09-5
Purity:  98.01%
Research Areas:  

Cancer

Tomaymycin DM is a derivative of Tomaymycin (HY-N10174) that belongs to the class of DNA alkylation inhibitors and acts as an effective payload for ADCs. Tomaymycin stabilizes the double-stranded DNA structure, inhibits various DNA processing enzymes, blocks transcription, and ultimately induces DNA strand breaks and apoptosis. Tomaymycin DM can be used in studies related to the development of ADCs targeting multiple cancers including leukemia and ovarian cancer .
loading...
    loading...
Cat. No.: HY-171081
CAS No.: 2117643-80-6
Research Areas:  

Cancer

Glucocorticoid receptor agonist-6 (Compound A) is a Glucocorticoid receptor (GR) agonist. Glucocorticoid receptor agonist-6 can be used as a cytotoxic payload for synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
Cat. No.: HY-176843
CAS No.: 3083974-69-7
Research Areas:  

Cancer

eIF4A-IN-2 (Compound 93) is an Eukaryotic translation initiation factor 4A (eIF4A) inhibitor. eIF4A-IN-2 can be used as a cytotoxic payload for synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
Cat. No.: HY-175004
CAS No.: 1821339-88-1
Research Areas:  

Cancer

PBD dimer-4 (Compound 7) is a C1-subsitituted PBD dimer. PBD dimer-4 has high DNA-binding affinity, DNA cross-linking ability and potent cytotoxicity against MDA-MB-231 cells (IC50: 236 nM). PBD dimer-4 can be used as a payload of ADC Loncastuximab tesirine (HY-P99349) to treat several different cancer types .
loading...
    loading...
Cat. No.: HY-178270
CAS No.: 2305851-17-4
Target:  

ADC Payloads

Research Areas:  

Inflammation/Immunology Cancer

PBD derivative-1 (Compound 7-8) is a derivative of PBD, and PBD is the payload in antibody-drug conjugates (ADCs). PBD derivative-1 can be used for the synthesis of ADCs.
loading...
    loading...
Cat. No.: HY-164759
CAS No.: 2592504-89-5
Target:  

ADC Payloads NAMPT

Research Areas:  

Cancer

Nampt-IN-13 is a NAMPT inhibitor that serves as a payload for the synthesis of ADCs. Nampt-IN-13 is applicable to cancer-related research .
loading...
    loading...
Cat. No.: HY-135901
CAS No.: 2412924-07-1
Target:  

ADC Payloads Bacterial

Research Areas:  

Cancer

Py-MPB-amino-C3-PBD is a cytotoxic agent comprised non-alkylating group. Py-MPB-amino-C3-PBD acts as the payload for ADCs. Antimicrobial activity .
loading...
    loading...
Cat. No.: HY-W1117786
CAS No.: 2241015-68-7
Target:  

ADC Payloads NAMPT

Research Areas:  

Cancer

Nampt-IN-10 (Compound 4) is an efficient inhibitor of nicotinamide phosphoribosyltransferase (NAMPT). Nampt-IN-10 exhibits nanomolar-level inhibitory activity against cell lines such as MDA-MB453, NCI-N87, and NCI-H526. Nampt-IN-10 can be used as an ADC payload, and the ADC constructed with it as the core demonstrates significant anti-tumor activity .
loading...
    loading...
Cat. No.: HY-13631K
CAS No.: 2766786-58-5
Target:  

ADC Payloads

Research Areas:  

Cancer

(1R,9S)-Dxd is an isomer of (Dxd) HY-13631D. (1R,9S)-Dxd is an ADC payload that can be used in the synthesis of ADCs (antibody-drug conjugates) .
loading...
    loading...
Cat. No.: HY-176777
CAS No.: 2927485-59-2
Research Areas:  

Cancer

7-Methylol-9-methoxy-10-F-camptothecin (Compound D6-1) is a derivative of Camptothecin (HY-16560). 7-Methylol-9-methoxy-10-F-camptothecin can be used as a cytotoxic payload for synthesis of antibody-drug conjugates (ADCs) .
loading...
    loading...
Cat. No.: HY-164705
CAS No.: 2592504-91-9
Research Areas:  

Cancer

Mal-Toxophore is a drug-linker conjugate for ADC and can be used for ADC synthesis. The payload is a NAMPT inhibitor (HY-164759) .
loading...
    loading...
Cat. No.: HY-176455
Research Areas:  

Cancer

ADC-5 drug-linker (Compound linker-payload 5) is a drug-linker conjugate for ADC with potent anti-tumor activity. ADC-5 drug-linker can be used to synthesize NLRP3 agonist 3 (HY-176452) .
loading...
    loading...
Cat. No.: HY-132162B
CAS No.: 2378428-15-8
Target:  

ADC Payloads

Research Areas:  

Cancer

7-MAD-MDCPT TFA, a Camptothecin analog, is a toxin payload in antibody drug conjugates (ADCs) .
loading...
    loading...
Cat. No.: HY-157078
CAS No.: 1629735-05-2
Target:  

ADC Payloads

Research Areas:  

Cancer

Eg5-IN-2 (Compound Scaffold B (4)) is an Eg5 inhibitor (IC50: < 0.5 nM). Eg5-IN-2 can be used as an ADC payload for synthesis of ADCs .
loading...
    loading...
Cat. No.: HY-164730
Synonyms: ADCT-602; hLL2-Cys-PBD
Research Areas:  

Cancer

Epratuzumab Tesirine (ADCT-602) is a novel CD22-targeted ADC. Epratuzumab Tesirine contains a PBD dimer and a payload SG3249 .
loading...
    loading...
Cat. No.: HY-130161
CAS No.: 110429-45-3
Research Areas:  

Cancer

m-PEG4-Br is a cleavable ADC linker used in the synthesis of antibody-drug conjugate (ADC) for Trastuzumab (HY-P9907). m-PEG4-Br is placed distally from the monomethyl auristatin E (MMAE) payload to yield an ADC with altered hydrophilicity, antigen binding, and in vitro potency . m-PEG4-Br also can be used as a PROTAC linker that can be used in the synthesis of PROTACs.
loading...
    loading...